TP53 and cancer: The DEGs were significantly abundant in cell cycle and carcinogenesis-related pathways, such as cell cycle, platinum drug resistance, cancer pathways, p53 signaling, DNA replication, and AMPK signaling pathway, according to KEGG enrichment analysis (Figure 4a).